Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$0.87 - $1.05 $608 - $733
699 New
699 $0
Q4 2023

Feb 13, 2024

BUY
$0.9 - $1.06 $7,526 - $8,864
8,363 New
8,363 $8,000
Q2 2023

Aug 14, 2023

BUY
$1.1 - $1.54 $4,046 - $5,665
3,679 Added 21.08%
21,134 $25,000
Q1 2023

May 09, 2023

SELL
$1.19 - $2.09 $9,304 - $16,341
-7,819 Reduced 30.94%
17,455 $22,000
Q4 2022

Feb 10, 2023

BUY
$1.67 - $2.35 $31,198 - $43,902
18,682 Added 283.4%
25,274 $47,000
Q3 2022

Nov 10, 2022

BUY
$1.81 - $2.76 $5,808 - $8,856
3,209 Added 94.86%
6,592 $13,000
Q2 2022

Aug 15, 2022

SELL
$1.34 - $5.34 $2,239 - $8,923
-1,671 Reduced 33.06%
3,383 $7,000
Q1 2022

May 12, 2022

SELL
$4.58 - $6.8 $109,521 - $162,608
-23,913 Reduced 82.55%
5,054 $23,000
Q4 2021

Feb 14, 2022

SELL
$5.23 - $7.18 $62,440 - $85,722
-11,939 Reduced 29.19%
28,967 $186,000
Q3 2021

Nov 15, 2021

BUY
$5.94 - $8.75 $165,951 - $244,457
27,938 Added 215.44%
40,906 $253,000
Q2 2021

Aug 16, 2021

SELL
$7.54 - $9.79 $41,198 - $53,492
-5,464 Reduced 29.64%
12,968 $104,000
Q1 2021

May 17, 2021

BUY
$4.76 - $11.25 $30,035 - $70,987
6,310 Added 52.05%
18,432 $178,000
Q4 2020

Feb 16, 2021

SELL
$2.43 - $5.42 $112,773 - $251,536
-46,409 Reduced 79.29%
12,122 $59,000
Q3 2020

Nov 16, 2020

BUY
$2.3 - $3.72 $109,153 - $176,543
47,458 Added 428.59%
58,531 $146,000
Q2 2020

Aug 13, 2020

BUY
$1.33 - $3.63 $5,814 - $15,870
4,372 Added 65.24%
11,073 $35,000
Q1 2020

May 15, 2020

BUY
$1.27 - $2.33 $8,383 - $15,380
6,601 Added 6601.0%
6,701 $10,000
Q4 2019

Feb 07, 2020

SELL
$1.3 - $2.72 $1,817 - $3,802
-1,398 Reduced 93.32%
100 $0
Q3 2019

Nov 05, 2019

BUY
$1.93 - $4.21 $2,891 - $6,306
1,498 New
1,498 $4,000
Q1 2019

May 14, 2019

SELL
$1.79 - $3.12 $8,375 - $14,598
-4,679 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.24 - $3.9 $10,480 - $18,248
4,679 New
4,679 $12,000
Q3 2018

Nov 13, 2018

SELL
$3.58 - $4.9 $4,163 - $5,698
-1,163 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$4.43 - $5.14 $5,152 - $5,977
1,163 New
1,163 $6,000
Q1 2018

May 15, 2018

SELL
$4.65 - $5.9 $54,511 - $69,165
-11,723 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$4.32 - $5.52 $20,532 - $26,236
4,753 Added 68.19%
11,723 $54,000
Q3 2017

Nov 14, 2017

BUY
$4.35 - $5.25 $30,319 - $36,592
6,970
6,970 $37,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $78.9M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.